Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1999
08/12/1999CA2319567A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
08/12/1999CA2319555A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/12/1999CA2319448A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999CA2319236A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
08/12/1999CA2319097A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/12/1999CA2318857A1 Use of heregulin as an epithelial cell growth factor
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/12/1999CA2316860A1 Three-dimensional structures and models of fc receptors and uses thereof
08/12/1999CA2286174A1 Benzyloxy prodigiosine compounds
08/11/1999EP0934944A1 7-bromo- and 7,7-dibromo-cepham and cephem derivatives and their use as protease inhibitors
08/11/1999EP0934937A1 Azole derivatives as superoxide radical inhibitor
08/11/1999EP0934934A2 Methods of preparing substituted 3-phenyl- and 3-pyridyl-4(3H)-quinazolinones and atropisomers thereof
08/11/1999EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999EP0934745A1 Use of androsterone derivatives for inhibiting DNA binding of ap-1 and airway smooth muscle proliferation
08/11/1999EP0934531A1 Diagnosis of spongiform encephalopathy
08/11/1999EP0934422A2 Gene therapy for congestive heart failure
08/11/1999EP0934412A1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF
08/11/1999EP0934404A1 Inhibition of proliferation of cells
08/11/1999EP0934340A1 Novel compounds
08/11/1999EP0934326A1 Substituted aminoalkane phosphonic acids
08/11/1999EP0934325A1 Tetraphosphonate bicyclic trisanhydrides
08/11/1999EP0934321A1 Thienopyrimidine with phosphodiesterase v inhibiting effect
08/11/1999EP0934308A1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
08/11/1999EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999EP0934305A1 Integrin antagonists
08/11/1999EP0934304A1 2-pyrimidineamine derivatives and processes for their preparation
08/11/1999EP0934301A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999EP0934295A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics
08/11/1999EP0934293A1 Novel compounds and compositions for treating diseases associated with tryptase activity
08/11/1999EP0934292A1 Metalloproteinase inhibitors
08/11/1999EP0934291A1 Protease inhibitors
08/11/1999EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
08/11/1999EP0934273A1 New derivates from piperidine-keto acid, their preparation and use
08/11/1999EP0934271A1 Substituted arylalkylamines as neurokinin antagonists
08/11/1999EP0934267A1 $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS
08/11/1999EP0934264A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
08/11/1999EP0934086A1 Liquid embolic agents containing partially hydrolyzed polyvinyl acetate
08/11/1999EP0934074A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract
08/11/1999EP0934072A1 Manufacturing process for the production of purified transferrin
08/11/1999EP0934068A1 Compounds and methods
08/11/1999EP0934066A1 Il-8 receptor antagonists
08/11/1999EP0934065A1 Pharmaceutical compounds
08/11/1999EP0934060A1 Dietary supplements
08/11/1999EP0741724B1 Neuroprotective chroman compounds
08/11/1999EP0725651B1 Hemoregulatory peptides
08/11/1999EP0669937B1 Peptide inhibitors of fibronectin and related collagen-binding proteins
08/11/1999EP0642509B1 Novel potent inducers of terminal differentiation and methods of use thereof
08/11/1999EP0584223B1 Novel immunosuppressive compounds
08/11/1999EP0584185B1 Treatment of fatigue syndrome with cholinesterase inhibitors
08/11/1999CN1225639A Phosphinate based inhibitors of matrix metalloproteases
08/11/1999CN1225637A Pyrrole triazines and pyrimidines
08/11/1999CN1225631A Bioconjugates of manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysis for dismutating superoxide
08/11/1999CN1225630A Methanesulphonate salt of an arylpiperzine derived from tryptamine and its solvates for pharmaceutical use
08/11/1999CN1225629A Novel pyrrole derivatives
08/11/1999CN1225624A Inhibition of matrix metalloproteases by substituted phenethyl compounds
08/11/1999CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds
08/11/1999CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor
08/11/1999CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
08/11/1999CN1225620A Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
08/11/1999CN1225584A Tetrahydro-beta-carboline compounds
08/11/1999CN1225582A Use of carbonic anhydrase inhibitors for treating macular edema
08/11/1999CN1225362A Indole derivatives
08/11/1999CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/10/1999US5936123 Compounds such as 3-isopropyl-4-hydrazinobenzoic acid and its salts
08/10/1999US5936097 Antitumor agents
08/10/1999US5936089 Dipeptides which promote release of growth hormone
08/10/1999US5936084 Halo-substituted bisindolemaleimide protein kinase C inhibitors
08/10/1999US5936082 Metallocorrinoids as biologically compatible carriers of pharmacological agents
08/10/1999US5936067 Macrophage inflammatory protein variants
08/10/1999US5936066 Recombinant human interleukin-1α
08/10/1999US5936064 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
08/10/1999US5935996 Composition for stimulating osteogenesis and preventingreduction of bone salt
08/10/1999US5935995 Poly-, oligo- and monosaccharides of drugs, e.g. nitrogen mustard gas, quinine and dipyridamole; stability; slow release; antiarthitic agents; enzyme inhibitors
08/10/1999US5935985 Phenoxyacetic acid derivatives
08/10/1999US5935972 Benzofuran derivatives as tachykinin antagonists
08/10/1999US5935970 Treatment of nerve system disorders, neurodegenerative diseases
08/10/1999US5935960 Treatment of schizophrenia
08/10/1999US5935954 Compounds with improved multi-drug resistance activity
08/10/1999US5935953 Methods for controlling invertebrate pests using cocaine receptor binding ligands
08/10/1999US5935951 1-acyl-4-aliphatylaminopiperidine compounds
08/10/1999US5935947 Imidobisphosphoric acids, and use thereof
08/10/1999US5935931 Human apoptosis-related calcium-binding protein
08/10/1999US5935928 Modified platelet factor-4
08/10/1999US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas
08/10/1999US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo.
08/10/1999US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase.
08/10/1999US5935820 Polynucleotides encoding vascular endothelial growth factor 2
08/10/1999US5935819 Process for producing a pharmaceutical preparation of PDGF-AB
08/10/1999US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935798 Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
08/10/1999US5935602 Dosage forms of risedronate
08/10/1999US5935586 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin
08/10/1999US5935585 Novel compounds useful in topical and systemic treatment of dermatological conditions associated with a keratinization disorder, and inflammatory or immunoallergenic component; body and hair care cosmetics
08/10/1999US5935565 Method for increasing the level of stem cells in peripheral blood
08/10/1999CA2260698A1 Pyrrolidine and piperidine derivatives
1 ... 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 ... 1564